Insulin Glargine U 300
Indication
Type 2 diabetes mellitus
Amber level 0
Brand:
Toujeo®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Endocrine system
Background
Must be commenced by a healthcare professional who is appropriately trained and experienced in the initiation of insulin.
Insulin glargine 300 units/mL (Toujeo®) is recommended as an option in adults with type 2 diabetes mellitus (T2DM) only in accordance with the recommendations in NICE NG28 and in those who suffer from symptomatic nocturnal hypoglycaemia whilst being treated with a first-line long-acting insulin analogue.
The LSCMMG recommends Toujeo SoloStar® as the 1st line high strength long-acting insulin analogue.
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: